TrustCore Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.86M Hold
3,635
0.16% 72
2022
Q3
$1.65M Sell
3,635
-24
-0.7% -$11.5K 0.16% 74
2022
Q2
$1.77M Hold
3,659
0.16% 76
2022
Q1
$1.8M Buy
3,659
+2,662
+267% +$1.22M 0.16% 75
2021
Q4
$462K Buy
997
+7
+0.7% +$2.94K 0.05% 167
2021
Q3
$369K Buy
990
+17
+2% +$6.46K 0.04% 205
2021
Q2
$371K Buy
973
+24
+3% +$9.17K 0.04% 201
2021
Q1
$341K Buy
949
+16
+2% +$5.14K 0.04% 197
2020
Q4
$300K Buy
933
+250
+37% +$76.7K 0.04% 205
2020
Q3
$183K Buy
683
+68
+11% +$18.3K 0.03% 236
2020
Q2
$162K Buy
+615
New +$164K 0.03% 244
2019
Q4
Sell
-7
Closed -$2K 909
2019
Q3
$2K Buy
+7
New +$1.92K ﹤0.01% 850

Other funds holding ELV

TrustCore Financial Services's ELV Position: Q4 2022 in Review

TrustCore Financial Services held its Elevance Health (ELV) position steady in Q4 2022 at 3,635 shares worth $1.86M. The position accounts for 0.16% of the portfolio, ranked #72.

TrustCore Financial Services first reported a position in ELV in Q3 2019 and has held it in 12 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • TrustCore Financial Services held 3,635 shares of Elevance Health worth $1.86M as of Q4 2022.
  • TrustCore Financial Services left its Elevance Health share count unchanged in Q4 2022.
  • Elevance Health made up 0.16% of TrustCore Financial Services's portfolio in Q4 2022, its #72 holding.
  • TrustCore Financial Services first reported a position in Elevance Health in Q3 2019 and has held it in 12 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.